PPD

Research from the CWMH: Screening for Postpartum Depression, Treatment Engagement, Barriers to Care

Further systematic research on outcomes after postpartum screening is needed to ensure that screening translates into improved clinical outcomes.

By |2021-11-28T10:14:38-04:00November 23rd, 2021|Postpartum Depression, Postpartum Psychiatric Disorders, Research at CWMH|Comments Off on Research from the CWMH: Screening for Postpartum Depression, Treatment Engagement, Barriers to Care

Essential Reads: A Comprehensive Review of Brexanolone for the Treatment of Postpartum Depression

This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.

By |2021-11-02T10:53:02-04:00October 27th, 2021|Essential Reads, Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Essential Reads: A Comprehensive Review of Brexanolone for the Treatment of Postpartum Depression

For Women with Perinatal Mood and Anxiety Disorders, Can Nurses and Midwives Fill the Gaps in Mental Health Care?

Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.

By |2025-12-11T09:48:28-04:00October 26th, 2021|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on For Women with Perinatal Mood and Anxiety Disorders, Can Nurses and Midwives Fill the Gaps in Mental Health Care?

Essential Reads: Investigational Treatment of Depressive Disorders With Neuroactive Steroids: Potential Implications for PMDD

Neuroactive steroids, derivatives of allopregnanolone, may be effective for the treatment of premenstrual dysphoric disorder.

By |2021-09-30T10:02:07-04:00September 29th, 2021|Depressive Disorders, Essential Reads, Medication, PMS & PMDD, Treatment|Comments Off on Essential Reads: Investigational Treatment of Depressive Disorders With Neuroactive Steroids: Potential Implications for PMDD

NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone

NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression. 

By |2026-03-10T12:50:09-04:00September 2nd, 2021|Medication, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone

In Brief: Postpartum Depression Common in COVID-Positive Women Separated from Their Newborns

Women may experience depression and post-traumatic symptoms, especially those who were separated from their newborns after delivery and those with severe COVID-19 illness during pregnancy or after delivery. 

By |2021-06-15T10:14:11-04:00June 17th, 2021|Postpartum Depression, Postpartum Psychiatric Disorders, Prevalence & Risk Factors|Comments Off on In Brief: Postpartum Depression Common in COVID-Positive Women Separated from Their Newborns

Depression During the COVID-19 Lockdown Highlights the Importance of Social Connections for New Moms

Because pregnant and postpartum women face unique challenges in the context of the COVID-19 pandemic, they may be at increased risk for mental health problems in this setting.  In a recent study, researchers from the University College of London surveyed 162 new mothers in London between May and June 2020 using a social network survey designed to assess the impact of the COVID-19 lockdown. 

By |2021-05-18T13:56:11-04:00May 18th, 2021|Depressive Disorders, Postpartum Psychiatric Disorders|Comments Off on Depression During the COVID-19 Lockdown Highlights the Importance of Social Connections for New Moms
Go to Top